Inflammatory and coagulation biomarkers, including D-dimer, C-reactive protein (CRP), ferritin, interleukin-6 (IL-6), and procalcitonin, are routinely measured in moderate–severe COVID-19 and frequently inform clinical decision-making. The gene discussed is CRP; the disease is COVID-19.